Financhill
Back

Apellis Pharmaceuticals Vs. Rocket Lab USA Industry Stock Comparison

Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
$19.21
Seasonality Move:
-16.64%
Buy
84

RKLB
Rocket Lab USA

Last Price:
$39.15
Seasonality Move:
33.71%
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.21. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
84
Rocket Lab USA (RKLB) is a Buy

Is Rocket Lab USA a Buy, Sell or Hold?

  • The current Rocket Lab USA [RKLB] share price is $39.14. The Score for RKLB is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • RKLB is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RKLB Stock Price Chart

What is Rocket Lab USA's stock price today?

  • The Rocket Lab USA share price today is $39.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RKLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 57.88 Buy
Chaikin Money Flow: 3142813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.69 - 19.09) Buy
Bollinger Bands (100): (17.14 - 24.36) Sell

RKLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.51 Buy
Relative Strength Index (14 RSI): 73.54 Buy
Chaikin Money Flow: 10583526 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.84 - 35.9) Buy
Bollinger Bands (100): (18.54 - 29.72) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.9 Buy
20-day SMA: 18.23 Buy
50-day SMA: 18.18 Buy
200-day SMA: 25.58 Sell
8-day EMA: 18.16 Buy
20-day EMA: 18.15 Buy
50-day EMA: 18.77 Buy
200-day EMA: 25.96 Sell

RKLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.7 Buy
20-day SMA: 32.28 Buy
50-day SMA: 27.83 Buy
200-day SMA: 21.7 Buy
8-day EMA: 15.39 Buy
20-day EMA: 7.07 Buy
50-day EMA: 2.99 Buy
200-day EMA: 0.77 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $0.73 per share.

Rocket Lab USA Earnings Growth & RKLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.04 per share, and an increase next year of $0.27 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rocket Lab USA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):